Prev Chronic Dis by Kim, Sue E. et al.
PREVENTING  CHRONIC  DISEASE
P U B L I C  H E A L T H  R E S E A R C H ,  P R A C T I C E ,  A N D  P O L I C Y 
  Volume 16, E155                                                                         NOVEMBER 2019  
 
ORIGINAL RESEARCH
 
 
Evaluation of a Digital Diabetes Prevention
Program Adapted for Low-Income Patients,
2016–2018
 
Sue E. Kim, PhD, MPH1; Cynthia M. Castro Sweet, PhD2; Edward Cho, MD, MPH1;
Jennifer Tsai, PhD2; Michael R. Cousineau, DrPH1,3
 
Accessible Version: www.cdc.gov/pcd/issues/2019/19_0156.htm
Suggested citation for  this  article:  Kim SE, Castro Sweet CM,
Cho E, Tsai J, Cousineau MR. Evaluation of a Digital Diabetes
Prevention  Program  Adapted  for  Low-Income  Patients,
2016–2018.  Prev  Chronic  Dis  2019;16:190156.  DOI:  https://
doi.org/10.5888/pcd16.190156.
PEER REVIEWED
Summary
What is already known on this topic?
Diabetes Prevention Programs (DPPs) demonstrate that lifestyle changes
can be more effective than prescription medication to prevent or delay the
onset of diabetes. Although DPPs have focused on low-income communit-
ies and achieved promising results, in-person participation continues to be
a challenge.
What is added by this report?
Our study examined a digitally delivered DPP that removed some barriers
to access and increased participation for low-income patients.
What are the implications for public health practice?
We revealed that a digitally delivered intervention, allowing choice of ac-
cess, can be an effective option in preventing or delaying diabetes by in-
creasing participant engagement.
Abstract
Introduction
We examined the effects of a digitally delivered, type 2 diabetes
mellitus prevention program (DPP) for a low-income population.
Methods
We conducted a nonrandomized clinical trial with matched con-
trols. The intervention group was offered a digital DPP, a web-
based and mobile-based program including 52 weeks of partici-
pation in an educational curriculum, health coaching, and peer
support.
Results
A total  of 227 participants enrolled.  At baseline,  34.6 was the
mean body mass index, and 5.8 was the mean HbA1c. For the in-
tervention group, mean weight loss was 4.4% at the 12-month fol-
low-up.
Conclusion
The modified DPP successfully engaged participants and resulted
in weight loss. Low-income patients with prediabetes benefitted
from a digitally delivered diabetes intervention. This prevention
method should be accessible to a low-income population.
Introduction
In 2015, 84 million US adults were estimated to have prediabetes
and approximately 30 million were living with diabetes (1). While
diabetes prevention efforts increase, the incidence of type 2 dia-
betes mellitus and obesity remain disproportionately higher among
low-income patients, including those from underrepresented ra-
cial and ethnic groups (2,3).
The landmark Diabetes Prevention Program (DPP) demonstrated
that lifestyle modifications improve healthy diet, increase physic-
al activity, and sustain weight loss more effectively than prescrip-
tion medication in preventing or delaying the onset of diabetes
(4,5). The success of the DPP lifestyle intervention highlights the
role of behavioral interventions as effective, safe, and sustainable
for diabetes prevention (6–8). Translational efforts have dissemin-
ated the DPP through in-person groups, as well as online and di-
gital formats through remote coach access, internet platforms, tele-
communications, and smartphone apps, resulting in replication of
DPP goals (8,9).
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Some DPPs have targeted low-income communities with modest
but promising results (10–14). Recurring limitations in many of
these programs are dependency on face-to-face interactions, loca-
tion-based meetings, and time-restricted options for group ses-
sions. Limited flexibility of work schedules,  access to reliable
transportation,  and access to affordable childcare are reported
obstacles for participation in required, in-person DPP sessions
(15,16). Similarly, people in rural areas might live long distances
from the nearest DPP location, posing a transportation challenge.
Given low-income communities’ growing use and acceptance of
accessible technologies (17,18), a digitally delivered DPP might
be an option for hard-to-reach populations with prediabetes (19).
We examined the effectiveness of a digital DPP adapted for a low-
income population. We designed the study to measure partici-
pation in the program and its effectiveness in reducing risk for dia-
betes, compared with a nonparticipating matched group.
Methods
We conducted the intervention at a federally qualified health cen-
ter  and outpatient  clinic  in  a  large public  teaching hospital  in
Southern California and at a clinic within a private, integrated
health  care  network in  Washington State  from February 2016
through April 2018. The target population was adults (aged 18–75
years) enrolled in Medicaid or another safety-net insurance plan,
and with evidence of prediabetes in their electronic health record
(EHR). Our previous publication describes implementation of the
digital DPP for a low-income population, including study design,
protocol, and inclusion and exclusion criteria (20). We registered
this study at ClinicalTrials.gov (NCT02664064), and our analyses
are based on the previous protocol. The DPP used in this study
achieved Full  Recognition status from the Centers for Disease
Control and Prevention’s Diabetes Prevention Recognition Pro-
gram (21). Both the Western Institutional Review Board and the
Health Sciences Institutional Review Board at the University of
Southern California reviewed and approved this study’s protocol.
We identified participants through EHRs or by referrals from their
primary care physicians. In total, we identified and screened 273
participants who were eligible for inclusion in the study, and a di-
gital DPP was offered to all in the intervention group (Figure).
Figure.  Participant  selection  for  digitally  delivered  Diabetes  Prevention
Program  (DPP).  Abbreviations:  BMI,  body  mass  index;  DPP,  Diabetes
Prevention Program.
The intervention is a digital DPP that includes virtual group sup-
port, personalized health coaching, weekly lessons, and digital
progress tracking tools (20,22). The program begins with an in-
tensive  16-week  phase,  followed  by  a  36-week  maintenance
phase. Participants are assigned to small virtual groups with peers
and a health coach. Each group has a private online social net-
work to engage in discussion and provide social support (20). Par-
ticipants complete weekly health education lessons available on
the digital platform that can be accessed through the internet or
smartphones. Health coaches communicate with participants to
provide individual counseling through private messaging and fa-
cilitate group discussions through a chat  board.  The DPP cur-
riculum was adapted for low-income populations by rewriting
content at 4th- and 5th-grade reading levels, cultural tailoring and
Spanish translation, and adding bilingual and bicultural health
coaches. These adaptations were previously tested in a feasibility
study (20,23).
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Outcome measures
At baseline, study site coordinators recorded demographic data
(marital status, household size, sex, race/ethnicity, preferred lan-
guage, educational status, and current employment status), insur-
ance status, self-rated health, self-efficacy for diet and physical
activities, health beliefs, health care utilization, self-management,
comfort with technology, health literacy, and social support. We
collected these measures only for participants who received the in-
tervention; matched controls did not provide this information. Be-
cause not all participants were available for the 6-month or 12-
month follow-up at the same time, and to avoid overlapping times
between the 2 follow-up periods, we defined the first follow-up
time as T1 to approximate 6 months after baseline and included
data collected from 24 to 35 weeks. Time T2 approximates 12
months after baseline and included data collected from 47 to 65
weeks. We determined these points on sensitivity analyses of the
distribution and natural break when the majority of participants
completed each of the follow-ups. With the exception of demo-
graphics, we repeated all  measures in both interviewer-admin-
istered surveys at T1 and T2 (20).
Using calibrated equipment in the health clinics,  we measured
height  using  stadiometers  and  weight  using  weight  scales  at
baseline, T1, and T2. The primary outcome variable was change in
weight over time, both in pounds and as percentage change. In as-
sessing change in the comparison group, we used change in body
mass index (BMI, calculated as weight in kilograms divided by
height in meters squared [kg/m2]), because one of the study sites
did not provide separate weight and height data. Using self-admin-
istered AccuBase (DTI Laboratories) A1c finger-stick test kits, we
recorded glycosylated hemoglobin (HbA1c) in percentage units of
NGSP (formerly, National Glycohemoglobin Standardization Pro-
gram) and DCCT (Diabetes Control and Complications Trial). We
measured and defined engagement as the number of completed
lessons in the initial 16-week phase, with a range of 0 to 16.
Matched control group
Each study site provided control group data from de-identified re-
cords of patients who did not enroll in the trial, and each site used
the same criteria for study eligibility (24). We matched the control
group on age and sex.  Each site  searched for  matched control
cases within 12 months before the start of enrollment or concur-
rent with the enrollment period of the trial. This allowed a maxim-
um 24-month window to find a matched control group with at
least 2 measurements of BMI and HbA1c test results.
To create a control group that best matched the intervention group,
we used a one-to-many matching algorithm. We first identified all
possible matches for each intervention participant by setting exact
match criteria for sex and site location. To have at least 1 control
group match for each intervention case, we set participant age and
intervals between BMI measurements flexibly, with a range of 15
years  and  45  days,  respectively.  We  determined  the  flexible
matching criteria to optimize having at least 1 control match to an
intervention participant (24).
Statistical analyses
We set the study to detect a significant predifference and postdif-
ference of 3% weight loss in the intervention group relative to a
0% weight reduction expected in the control group. Based on a
similar study with comparable populations (25), we estimated a
4% standard  deviation  (SD)  across  groups.  With  α  =  .05  and
power = 0.8,  we estimated a minimal sample size of  40 parti-
cipants per group necessary to detect a 3% difference in weight
loss. Estimated churn rates for Medicaid varied between 20% and
50% (26,27), from which we expected a 30% and 40% baseline
loss to follow-up rate.
We examined weight loss as the primary outcome, as measured by
mean percentage weight loss from baseline to T1 and T2, as well
as the percentage who lost more than 5% of their baseline weight
and change in BMI from baseline to T1 and T2.  As a process
measure, we examined level of participation in the DPP, as meas-
ured by program engagement (defined as lesson completion) and
changes in HbA1c measurement from baseline to T1 and T2. Be-
cause of  the number of  participants  who did not  complete the
study and were excluded, we conducted an attrition analysis to de-
termine if biases were present in the sample of those who did com-
plete T1 and T2 assessments. We compared the demographic char-
acteristics of participants among 5 subgroups: the overall sample
of participants at baseline, participants with T1 follow-up data,
participants with T2 follow-up data, participants without T1 data,
and participants without T2 data.
We measured weight change at times T1 and T2 as a continuous
variable (percentage weight change). For the bivariate analyses,
we dichotomized the outcomes to 5% or less and above 5%. To
compare our findings to previous evaluations of DPP, we chose
the benchmark of 5% and examined outcomes anchored on lesson
completion (9). To test associations between key demographics
and predictor variables for percentage change in weight, we cre-
ated 3 regression models: 1) a continuous variable, 2) the odds of
losing more than 5% of baseline weight, and 3) engagement. Cov-
ariates were age, sex, race/ethnicity, insurance status, education,
employment, self-rated health, and self-efficacy at baseline. For
multivariate analyses, we examined ordinary least square regres-
sion models. Data analyses were performed using Stata 15 (Stata-
Corp, LLC).
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Results
Study recruitment, screening, and enrollment occurred during Feb-
ruary 2016 through March 2017. Participants at baseline (n = 227)
were predominantly women (81.3%), average age was of 48.2
years,  and 117 (51.5%) identified  their  ethnicity  as  Hispanic/
Latino (Table 1). A total of 106 (47.1%) indicated Spanish as their
preferred language, and 97 (43%) reported limited English profi-
ciency.
At baseline, 69 (30.4%) participants had a normal HbA1c (mean
5.3%; SD, 0.2%) and 7 (3.1%) participants had an HbA1c in the
diabetes range (mean, 6.6%; SD, 0.1%). Mean BMI was 34.6 (SD,
7.9), mean weight was 199.5 lb (SD, 55.6), and median weight
was 190 lb. Although all participant EHR laboratory reports indic-
ated prediabetes, defined as HbA1c level of 5.7%–6.4% in the pre-
ceding 6 months, baseline mean HbA1c test results indicated 5.8%
(SD, 0.4%).
In our comparison of the 5 subgroups, including groups of parti-
cipants lost to follow-up, we found that the groups were similar in
nearly all sociodemographic variables except insurance status and
employment.  Those lost  to  follow-up were less  likely to  have
Medicaid at T1 (P = .03) and T2 (P = .004) and more likely to
work full-time (P = .02) at T1. No other significant differences
were observed, indicating that those who were lost to follow-up
were sociodemographically similar to those who completed fol-
low-up.
In the weight-loss analyses for the 111 participants with complete
data at T1 and 104 participants with complete data at T2, we found
that overall, 45 (41%) of the participants had more than 5% weight
loss at  T1 and 38 (37%) had more than 5% weight loss at  T2.
Mean weight  loss  was  4.2% (SD,  6.6%) at  T1 and 4.4% (SD,
7.7%) at T2 (P < .001 for each). Mean BMI at T1 was 33.3, a
change of −1.5 from baseline (SD, 2.4; P < .001) and the mean at
T2 was 33.2, a change of −1.6 from baseline (SD, 2.7; P < .001).
We used BMI for the comparison analysis because separate weight
change data were not available for the control group.
In the bivariate analysis, we compared the results of participants
who  achieved  less  weight  loss  (≤5%)  with  participants  who
achieved more weight loss (>5%) from baseline to T1 and to T2.
At both T1 and T2, completing 9 or more lessons was signific-
antly associated with weight loss (T1, P = .001; T2, P = .003) (Ta-
ble 2). No difference in weight loss was associated with any so-
ciodemographic factors, self-reported health at baseline, BMI at
baseline, or HbA1c level at baseline.
Analysis  of  HbA1c  was  limited  to  study participants  who had
HbA1c measurements at baseline and T1 (n = 97) or baseline and
T2 (n = 91). Participants remained in the prediabetes range from
baseline to T1 (5.8% to 5.7%; P =.14) and T2 (5.7% to 6.0%; P <
.001).  Among participants  who lost  more than 5% of baseline
weight at T1, their HbA1c level decreased from an average of 5.8%
at baseline to 5.6% at T1(P = .009), but no significant difference
was observed at T2. For those who lost 5% or less of baseline
weight,  HbA1c  levels  were  the  same at  T1 as  baseline  but  in-
creased at T2 (from 5.8% at baseline to 6.1% at T2; P = .006).
Comparison group analysis
We found no overall difference in HbA1c between the intervention
(n = 95) and control (n = 95) group (0.07%, P =.22). The compar-
ison group analysis was limited to the T1 follow-up and included
109 participants (Figure). Although the comparison group also re-
quired 3 measurements of BMI and HbA1c within 12 months, we
were able only to obtain data close to T1 follow-up and not for T2.
Because we identified each control participant on an exact match
for sex, we found no differences in sex between the intervention
group and control group (81% female in both groups). Mean age
was 49.5 years for the intervention group and 50.6 years for the
control  group.  At baseline,  BMI was 34.8 for the intervention
group and 33.3 for the control. At T1, among control group parti-
cipants, we found no significant changes in BMI (33.3 at baseline
to ‒32.5 at T2) or in HbA1c. The mean time between baseline and
follow-up for the control group was 33 weeks for BMI and 37
weeks for HbA1c, compared with 29 weeks on average for both
measurements  for  the intervention group.  A t  test  comparison
showed a 3.3% (SD, 7.2%; P = .001) difference in the mean per-
centage change in BMI between the intervention and control group
at T1.
Multivariate regression analysis 
Some sociodemographic variables, such as race/ethnicity and edu-
cation,  were  associated  with  significant  weight  change  from
baseline to T2 (models 1 and 2). Compared with non-Hispanic
white participants, Hispanic/Latino participants were more likely
to gain weight (7.2%, 95% CI, 2.5%–11.8%) and had lower odds
of having more than 5% weight loss (odds ratio [OR], 0.14; 95%
CI, 0.03−0.72). Less than college education was significantly as-
sociated with weight loss (−5.7%; 95% CI, −9.1 to −2.3) and high-
er odds of having more than 5% weight loss (OR, 4.1; 95% CI,
1.1–15.6). Also, participants completing 9 or more lessons had
higher odds of having more than 5% weight loss (OR, 5.0; 95%
CI, 1.3–19.1). For model 3 showing predictors of engagement,
Hispanic/Latino participants (OR, 0.11; 95% CI, 0.02–0.65) and
participants who reported better health at baseline were less likely
to complete 9 or more lessons (OR, 0.52; 95% CI, 0.27–0.99) (Ta-
ble 3).
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Discussion
Our findings reveal that an online format for diabetes prevention
and lifestyle modification can benefit many low-income patients
who are at risk of diabetes and served by safety-net programs.
Among our group of low-income participants who met the criteria
for prediabetes, most continued the trial 1 year beyond enrollment.
More than one-half were highly engaged, completing at least 9
weekly lessons of the 16-week intensive program.
Recent data suggest that the vast majority of the US population
has access to various types of mobile technology, regardless of in-
come. Many low-income individuals use the technology of mo-
bile phones, and other devices have become less costly and more
widespread (28). Less than 10% of our enrollees failed to com-
plete the first required step of creating their program profile, indic-
ating that comfort or access to digital technology was not a major
barrier for people who want to improve their health.
The intervention helped people reduce their body weight from
baseline by about 4%. Approximately 41% of the intervention
group lost more than 5% of their baseline weight at T1 and 37% at
T2. Results revealed that a digital prevention program can lead to
successful weight loss. These results in weight loss are compar-
able to previous study findings that examined DPP participation of
non-Medicaid beneficiaries at mixed income levels (9,29). The
sustainability of weight loss for up to about 12 months in the inter-
vention group (in contrast to the control group, in which we ob-
served no change) indicates the effectiveness of the intervention in
engaging populations at risk of diabetes to help them achieve their
weight loss goals and reduce disease risk.
Our study has several limitations. We chose the study design of a
nonrandomized, matched controlled trial to pragmatically assess
the effectiveness of the DPP because there were no alternative pro-
grams readily available for the targeted population with predia-
betes. A more rigorous selection of the control group, rather than
the historical comparison group, would improve our ability to rule
out regression to the mean and other factors that drive change and
to  help  us  clearly  understand temporal  changes  in  health  out-
comes. Additionally, because we did not conduct intent-to-treat
analysis, our findings reflect data for participants who completed
either follow-up at T1, T2, or both. Our conclusions are generaliz-
able only to people who are likely to remain engaged. Nonethe-
less, the relative value of additional efficacy data on the DPP from
highly structured randomized trials is debatable, relative to the
value of more real-world tests of the program in underserved pop-
ulations.
Another  limitation  is  that  we  do  not  know  why  participants
dropped out of the study or were lost to follow-up. When an inter-
vention such as the DPP is offered to Medicaid beneficiaries and
other safety-net populations, the expectation is that there will be a
fair amount of attrition, given the high churn rate known among
Medicaid enrollees as a result of competing life events, such as
dealing with employment and family issues.
Although the in-person DPP is available to low-income popula-
tions, barriers to participation exist, such as time constraints, trans-
portation, childcare, or other logistical factors that impede attend-
ance in location-based meetings. Therefore, consideration must be
given to other platforms, including digitally delivered DPPs that
can remove some barriers and improve access and engagement. As
providers and health policy makers consider options to prevent
diabetes, this study shows that a digitally delivered intervention
can be an effective option for this population, and people should
be given choices of and access to digital diabetes prevention solu-
tions to improve their health.
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Tables
Table 1. Participant Demographics in Digital Diabetes Program at Baseline and Each Follow-Upa
Demographicsc
Baseline T1 Participantsb T2 Participantsb Full Cohort
All Participants
(n = 227)
With Follow-Up
Data (n = 111)
Without Follow-Up
Data (n = 116)
With Follow-Up
Data (n = 104)
Without Follow-Up
Data (n = 123)
Baseline, T1, and
T2 (n = 76)
Age, mean (standard deviation), y 48.2 (11.7) 49.5 (10.6) 47.0 (12.6) 48.8 (10.6) 47.6 (12.5) 50.2 (9.9)
Female 183 (81.3)c 90 (81.8) 93 (80.9) 81 (78.6) 102 (83.6) 61 (81.3)
Race/ethnicity
Non-Hispanic white 37 (16.3) 22 (19.8) 15 (12.9) 20 (19.2) 13.8 (17) 17 (22.4)
Hispanic/Latino 117 (51.5) 58 (52.3) 59 (50.9) 54 (51.9) 63 (51.2) 38 (50.0)
African American 16 (7.1) 11 (9.9) 5 (4.3) 7 (6.7) 9 (7.3) 6 (7.9)
Other or preferred not to answer 56 (25.0) 20 (18.0) 37 (31.9) 23 (22.1) 34 (27.6) 15 (19.7)
Language preference
English 119 (52.9) 56 (50.9) 63 (54.8) 54 (52.9) 65 (52.9) 39 (52.0
Spanish 106 (47.1) 54 (48.6) 52 (45.2) 48 (47.1) 58 (47.2) 36 (48.0)
Insurancec,d
Medicaid or Medi-Cal 84 (37.0) 49 (44.1) 35 (30.2) 49 (47.1) 35 (28.5) 39 (51.3)
Other program for uninsured 143 (63.0) 62 (55.9) 81 (69.8) 55 (52.8) 88 (71.5) 37 (48.7)
Education
Some high school 86 (38.4) 42 (37.8) 44 (37.9) 40 (38.8) 46 (37.4) 31 (40.8)
High school diploma or GED 46 (20.5) 25 (22.5) 21 (18.1) 24 (23.3) 22 (18.0) 17) (22.4)
Some college or college graduate 92 (41.1) 44 (39.6) 48 (41.3) 39 (37.9) 53 (43.1) 28 (36.8)
Employmente
Unemployed 104 (47.1) 59 (55.1) 45 (39.5) 51 (50.0) 53 (44.5) 41 (55.4)
Employed part-timef 51 (23.1) 25 (23.4) 26 (22.8) 25 (24.5) 26 (21.9) 17 (23.0)
Employed full-timef 66 (29.9) 23 (21.5) 43 (37.7) 26 (25.5) 40 (33.6) 16 (21.1)
Self-rated health at baseline
Excellent or very good 117 (55.9) 55(56.7) 62 (55.4) 54 (56.0) 63 (53.9) 36 (55.4)
Good 71 (34.0) 36 (37.1) 35 (31.3) 30 (32.6) 41 (35.0) 24 (36.9)
Fair or Poor 21 (10.1) 6 (6.2) 15 (13.4) 8 (8.7) 13 (11.1) 5 (7.7)
Self-efficacy composite score at
baselineg, mean (SD)
41.8 (7.8) 41.1 (8.3) 42.4 (7.4) 42.2 (8.1) 41.5 (7.7) 42.0 (8.3)
BMI (weight in kg/height in square meters) at baseline
Normal (18.5–<25) 9 (4.0) 3(2.7) 6 (5.2) 5 (4.8) 4 (3.3) 3 (4.0)
Abbreviations: BMI, body mass index; GED, general education diploma; SD, standard deviation.
a All numbers are indicated as number and percentage, unless otherwise stated.
b T1, data collected at approximately 6 months after baseline or 24 to 35 weeks; T2, data collected at approximately 12 months after baseline or 47 to 65 weeks.
c Percentages may not add to 100% because of rounding and missing data.
d Insurance: T1, P = .03; T2, P = .004; and full cohort, P = .002, determined by χ2 test.
e Employment: T1, P = .02, determined by χ2 test.
f Employment full-time, >40 hours per week; employment part-time <40 hours per week.
g Self-efficacy composite score for diet and physical activity; sum of 13 items scored from 13 to 52 (each item scored as 1, confident; 2, little confident; 3, some-
what confident; and 4, completely confident).
(continued on next page)
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(continued)
Table 1. Participant Demographics in Digital Diabetes Program at Baseline and Each Follow-Upa
Demographicsc
Baseline T1 Participantsb T2 Participantsb Full Cohort
All Participants
(n = 227)
With Follow-Up
Data (n = 111)
Without Follow-Up
Data (n = 116)
With Follow-Up
Data (n = 104)
Without Follow-Up
Data (n = 123)
Baseline, T1, and
T2 (n = 76)
Overweight (25–<30) 66 (29.1) 35 (31.5) 31 (26.7) 26 (25.0) 40 (32.5) 22 (29.0)
Obese (≥30) 152 (67.0) 73 (65.8) 79 (68.1) 73 (70.2) 79 (64.2) 51 (67.1)
Abbreviations: BMI, body mass index; GED, general education diploma; SD, standard deviation.
a All numbers are indicated as number and percentage, unless otherwise stated.
b T1, data collected at approximately 6 months after baseline or 24 to 35 weeks; T2, data collected at approximately 12 months after baseline or 47 to 65 weeks.
c Percentages may not add to 100% because of rounding and missing data.
d Insurance: T1, P = .03; T2, P = .004; and full cohort, P = .002, determined by χ2 test.
e Employment: T1, P = .02, determined by χ2 test.
f Employment full-time, >40 hours per week; employment part-time <40 hours per week.
g Self-efficacy composite score for diet and physical activity; sum of 13 items scored from 13 to 52 (each item scored as 1, confident; 2, little confident; 3, some-
what confident; and 4, completely confident).
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Table 2. Participant Weight Loss by Demographic Characteristic at Each Follow-Up
Characteristic
T1 T2
Pounds Lost
(n = 111)a
≤5% Body Weight
Lost (n = 66)b,c
>5% Body Weight
Lost (n = 45)b,c
Pounds Lost
(n = 104)a
≤5% Body Weight
Lost (n = 66)b,c
>5% Weight Lost
(n = 38)b,c
Age, no. of particiants
(mean in years)[SD]
NA 65 (48.4) [11.3] 45 (51.0) [9.3] NA 66 (48.8) [10.2] 37(48.7) [11.5]
Sex
Male 20 (14) [16.8] 9 (45.0) 11 (55.0) 22 (10.2) [13.1] 15 (68.2) 7 (31.8)
Female 90 (7.2) [13.2] 56 (62.2) 34 (37.8) 81 (8.2) [15.5] 50 (61.7) 31 (38.3)
Race/ethnicity
Non-Hispanic white 22 (12.1) [16.1] 10 (45.5) 12 (54.6) 20 (16.6) [16.2] 8 (40.0) 12 (60.0)
Hispanic/Latino 58 (7.5) [14.1] 37 (63.8) 21 (36.2) 54 (5.6) [12.1] 38 (70.4) 16 (29.6)
African American 11 (5.6) [7.6] 6 (54.6) 5 (45.5) 7 (2.4) [16] 5 (71.4) 2 (28.6)
Other/preferred not to
answer
20 (8.4) [14.4] 13 (65.0) 7 (35.0) 23 (10.1) [17.2] 15 (65.2) 8 (34.8)
Language preference
English 56 (9.7) [16.4] 32 (57.1) 24 (42.9) 54 (10.7) [17.0] 31 (57.4) 23 (42.6)
Spanish 54 (7.2) [11.3] 33 (61.1) 21(38.9) 48 (6.1) [12.3] 34 (70.8) 14 (29.2)
Insurance
Medicaid or Medi-Cal 49 (15.4) [−7.3] 32 (65.3) 17 (34.7) 49 (15.9) [−7.5] 34 (69.4) 15 (30.6)
Other program for
uninsured
62 (13.0) [−9.3] 34 (54.8) 28 (45.2) 55 (14.2) [−9.4] 32 (58.2) 23 (41.8)
Educationd
Some high school 42 (12.4) [−7.4] 27 (64.3) 15 (35.7) 40 (12.6) [−9.7] 24 (60.0) 16 (40.0)
High school diploma or GED 25 (14.4) [−14.4] 114 (4.0) 14 (56.0) 24 (16.6) [−12.2] 14 (58.3) 10 (41.7)
Some college or college
graduate
44 (14.70 [−6.0] 28 (63.6) 16 (36.4) 39 (15.0) [−4.2] 28 (71.8) 11 (28.2)
Employmente
Unemployed 59 (14.0) −9.7] 32 (54.2) 27 (45.8) 51 (16.4) [−10.2] 29 (56.9) 22 (43.1)
Employed part-time 25 (13.2) [−6.8] 15 (60.0) 10 (40.0) 25 (−7.5) [16.2] 16 (64.0) 9 (36.0)
Employed full-time 23 (−7.5) (15.8) 17 (73.9) 6 (26.1) 26 (10.2) [−7.1] 19 (73.1) 7 (26.9)
Self-rated health
Excellent or very good 55 (14.0) [−8.0] 32 (58.2) 23 (41.8) 54 (14.5) [−8.2] 34 (62.7) 20 (37.0
Good 36 (14.5) [−6.6] 25 (69.4) 11 (30.6) 30 (16.2) [−7.7] 20 (66.7) 10 (33.3)
Fair or poor 6 (8.10) [−12.3] 3 (50.0) 3 (50.0) 8 (11.2) [−11.7] 5 (62.5) 3 (37.5)
Self-efficacy composite NA 66 (41.3) [8.2] 45 (44.9) [7.4] NA 66 (40.6) [8.0] 38 (43.9) [7.4]
Abbreviations: GED, general education diploma; NA, not applicable; SD, standard deviation; T1, data collected at approximately 6 months after baseline or 24–35
weeks; T2, data collected at approximately 12 months after baseline or 47–65 weeks.
a Values are number of participants (mean lb) [SD lb] unless otherwise noted.
b Values are number (percentage) of participants unless otherwise noted.
c For T1 and T2, percentages in ≤5% and >5% columns may not add to 100% because of rounding and missing data.
d Education: mean weight loss at T1, P = .05, determined by ANOVA.
e Employed part-time, work <40 hours/week; Employed full-time, work ≥40 hours/week.
f Self-efficacy composite score for diet and physical activity: T1, P = .02 and T2, P = .04, determined by t test.
g Engagement: T1, mean weight loss, P =.02, determined by χ2; percent body weight loss T1, P=.001 and T2, P=.003, determined by χ2 test.
(continued on next page)
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(continued)
Table 2. Participant Weight Loss by Demographic Characteristic at Each Follow-Up
Characteristic
T1 T2
Pounds Lost
(n = 111)a
≤5% Body Weight
Lost (n = 66)b,c
>5% Body Weight
Lost (n = 45)b,c
Pounds Lost
(n = 104)a
≤5% Body Weight
Lost (n = 66)b,c
>5% Weight Lost
(n = 38)b,c
score, n (mean score) [SD],f
Level of engagementg
<9 Lessons at 16 wk 37 (−3.9) [11.7] 30 (81.1) 7 (18.9) 35 (-5.0) [10.5] 29 (82.9) 6 (17.1)
≥9 Lessons at 16 wk 74 (-10.7) [14.6] 36 (48.7) 38 (51.4) 69 (-10.3) [16.6] 37 (53.6) 32 (46.4)
Baseline body mass index
Overweight (25–<30) 35 (-8.2) [9.5] 19 (54.3) 16 (45.7) 26 (−7.8) [12.5] 14 (53.9) 12 (46.2)
Obese (≥30) 73 (-8.6) [16.1] 44 (60.3) 29 (39.7) 73 (-8.7) [16.0] 49 (67.1) 24 (32.9)
Abbreviations: GED, general education diploma; NA, not applicable; SD, standard deviation; T1, data collected at approximately 6 months after baseline or 24–35
weeks; T2, data collected at approximately 12 months after baseline or 47–65 weeks.
a Values are number of participants (mean lb) [SD lb] unless otherwise noted.
b Values are number (percentage) of participants unless otherwise noted.
c For T1 and T2, percentages in ≤5% and >5% columns may not add to 100% because of rounding and missing data.
d Education: mean weight loss at T1, P = .05, determined by ANOVA.
e Employed part-time, work <40 hours/week; Employed full-time, work ≥40 hours/week.
f Self-efficacy composite score for diet and physical activity: T1, P = .02 and T2, P = .04, determined by t test.
g Engagement: T1, mean weight loss, P =.02, determined by χ2; percent body weight loss T1, P=.001 and T2, P=.003, determined by χ2 test.
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Table 3. Multivariate Regression Analysis of Participant Weight Change and Engagement
Characteristic
Model 1a,b
% Weight Change at T2
OLS: Coefficient Estimates (95% CI)
Model 2a,b
>5% Weight Change at T2
Logit: Odds Ratio (95% CI)
Model 3a,b
Engagement at T2
Logit: Odds Ratio (95% CI)
Age c 0.12 (−0.05 to −0.3) 0.94 (0.9 to −1.00) 1 (0.9 to −1.1)
Sex
Male 1 [Reference] 1 [Reference] 1 [Reference]
Female 0.86 (−2.8 to 4.5) 1.02 (0.3 to 4.1) 1.49 (0.4 to 5.2)
Race/ethnicity
Non-Hispanic white 1 [Reference] 1 [Reference] 1 [Reference]
Hispanic/Latino 7.17 (2.5 to −11.8) 0.14 (0.03 to −0.7) 0.11 (0.02 to −0.65)
Other 1.97 (−2.7 to −6.6) 0.42(0.09 to −2.1) 0.35 (0.06 to −2.1)
Insurance status
Medicaid or Medi-Cal 1 [Reference] 1[Reference] 1[Reference]
Other programs for uninsured −0.05 ( −3.5 to 3.4) 1.38 (0.4 to 5.1) 2.89 (0.9 to 9.3)
Education
Some high school, GED, or high school
graduate
−5.72 (−9.1 to −2.3) 4.14 (1.1 to −15.6) 0.57 (0.2 to 1.9)
Some college or college graduate 1 [Reference] 1 [Reference] 1 [Reference]
Employment
Unemployed −3.24 (-7.1 to –0.6) 4.17d (1.0 to 17.1) 0.76 (0.2 to 2.9)
Employed part-time -0.55 (−4.8 to 3.7) 1.72 (0.4 to 8.2) 0.96 (0.2 to 4.3)
Employed full-time 1 [Reference] 1 [Reference] 1 [Reference]
Level of engagement
<9 Lessons 1 [Reference] 1 [Reference] NA
≥9 Lessons -3.00 (-6.3 to –0.3) 5.01 (1.3 to 19.1) NA
Self-rated health -1.35 (-3.3 to 0.6) 1.33 (0.7–2.7) 0.52 (0.27 to .99)
Self-efficacy composite scored -0.15 (-0.4 to –0.1) 1.04 (1.0 to 1.1) 1.07 (1.0 to 1.2)
a Abbreviations: CI, confidence interval; GED, general education diploma; NA, not applicable; OLS, ordinary least squares.
b Model 1, OLS using percentage change in weight as a continuous variable; Model 2, logit model of weight loss, defined as ≤5% or >5% weight loss from baseline;
Model 3, logit model of engagement, defined as <9 lessons or ≥9 lessons.
c Age is a continuous variable in years.
d Self-efficacy composite score for diet and physical activity: T1, P = .02 and T2, P = .04, determined by t test.
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